Theranostics 2015; 5(11):1264-1274. doi:10.7150/thno.11848 This issue

Research Paper

Biomimetic Acoustically-Responsive Vesicles for Theranostic Applications

Chen-Chan Hsieh, Shih-Tsung Kang, Yee-Hsien Lin, Yi-Ju Ho, Chung-Hsin Wang, Chih-Kuang Yeh, Chien-Wen Chang

Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, 30013, Taiwan

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See for full terms and conditions.
Hsieh CC, Kang ST, Lin YH, Ho YJ, Wang CH, Yeh CK, Chang CW. Biomimetic Acoustically-Responsive Vesicles for Theranostic Applications. Theranostics 2015; 5(11):1264-1274. doi:10.7150/thno.11848. Available from

File import instruction


Graphic abstract

In recent years, biomimetic cell membrane-derived particles have emerged as a new class of drug delivery system with advantages of biocompatibility, ease of isolation and long circulation profile. Here we report the development and potential theranostic applications of a new biomimetic acoustically-responsive droplet system derived from mammalian red blood cell membrane (RBCM). We hypothesized that drug-loaded RBCM droplets (RBCMDs) would undergo a transition from liquid (droplets) to gas (bubbles) upon high intensity focused ultrasound (HIFU) insonation, resulting in on-demand drug release. The generated microbubbles could also serve as a contrast agent to enhance ultrasound imaging. As-synthesized RBCMDs exhibited uniform size, good dispersity and preservation of RBCM-associated proteins that prevented uptake by macrophages. Camptothecin (CPT), an anti-cancer drug, was successfully loaded in the RBCMDs with a loading efficiency of 2-3% and an encapsulation efficiency of 62-97%. A short (3 min) exposure to HIFU irradiation triggered release of CPT from the RBCMDs and the physical explosion of droplets damaged nearby cancer cells resulting in significant cell death. In addition, the acoustically vaporized RBCMDs significantly increased the ultrasound echo signal to 30 dB. Lastly, we demonstrated that RBCMDs could be acoustically vaporized in vivo in target tissues, and enhancing ultrasound imaging. Taken together, we have developed a new class of naturally derived RBCMDs which show great potential for future application in remotely triggered drug delivery and ultrasound imaging enhancement.

Keywords: red blood cell membrane, ultrasound theranostics, remotely triggerable drug delivery, cancer therapy, biomimetic vesicles.